Toplu, Sibel AltunisikErsoy, YaseminBayindir, YasarKilic, TalatBayazit, Volkan2024-08-042024-08-0420212149-20422149-4606https://doi.org/10.5222/MMJ.2021.95422https://search.trdizin.gov.tr/yayin/detay/487293https://hdl.handle.net/11616/92599Weeks and even months after recovering from the SARS-CoV-2 infection, clinically more severe cases are being reported, which are suggestive of COVID-19-related multisystemic inflammatory syndromes (MIS). Firstly on March 2020, this condition was reported to be COVID-19 related to children (MIS-C). Since June 2020, a syndrome similar to multisystem inflammatory syndrome in adults (MIS-A) came to be noticed in adults as well. We reported here a case of 24-year-old young woman who had gone to a hospital with abdominal pain and later developed a severe cough, followed by development of subconjunctival bleeding, pericardial effusion, pleural effusion, and intra-abdominal fluid that we deemed them to be acute multisystemic clinical symptoms, 47 days after she had undergone a COVID-19 infection of mild clinical severity. It should be kept in mind that a multisystemic inflammatory syndrome along with a delayed immune response during COVID-19 disease can be seen not only in children but also in young adults, and seemingly severe clinical and laboratory findings can improve by controlling the inflammatory process.eninfo:eu-repo/semantics/openAccessCOVID-19Multisystemic Inflammatory Syndrome in Adults (MIS-A)abdominal achesubconjunctival bleedingpericardial effusionpleural effusionArticle3621801843423977010.5222/MMJ.2021.954222-s2.0-85109320201Q4487293WOS:001109453000002N/A